Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

ARCA reports phase IIb study results for Gencaro in atrial fibrillation

Feb. 27, 2018

Daiichi Sankyo submits regulatory filing for esaxerenone in Japan

Feb. 27, 2018

ALDA-1 ameliorates myocardial injury after hemorrhagic shock in rats

Feb. 27, 2018

La Jolla Pharmaceutical treats first patient in Giapreza pediatric study

Feb. 23, 2018

Kancera considers development of KAND-567 in cancer and cardiovascular disease

Feb. 20, 2018

Dosing begins in phase Ib study of MYK-491

Feb. 19, 2018

Novoheart and Sumocor enter agreement to develop therapeutics for heart failure

Feb. 19, 2018

Chengdu Easton Pharmaceutical discloses IP receptor agonists

Feb. 15, 2018

Acesion Pharma cleared to conduct phase I study of AP-30663

Feb. 12, 2018

Fujifilm and Takeda establish regenerative medicine collaboration to treat heart failure

Feb. 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...